Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Breakthrough Spotting clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Breakthrough Spotting: 1 US clinical trial tracked, none currently recruiting.

Breakthrough Spotting is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Scott and White Hospital & Clinic, running 1 of these trials.

Enrollment posture brief

Registry condition breakthrough-spotting

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Breakthrough Spotting (this)0%
Open-enrollment share among volume-matched conditions near Breakthrough Spotting

Breakthrough Spotting has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Breakthrough Spotting on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Breakthrough Spotting is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Breakthrough Spotting records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

If bleeding does not remove ring Other
1 trials
remove ring if bleeding or spotting occurs more than 5 days Other
1 trials

US sites by state

Facility locations filed on Breakthrough Spotting trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Breakthrough Spotting page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Breakthrough Spotting trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Scott and White Hospital & Clinic sponsors the most Breakthrough Spotting trials on record, review their full trial history before evaluating a specific study. See Scott and White Hospital & Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breakthrough Spotting condition card totals 1 registered trials; most-linked intervention If bleeding does not remove ring; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.